S.21.05 Influences of European regulatory issues on the development of new therapies in children von Gispen-de Wied, C.C, van Zwieten-Boot, B.J

Volltext

Schizophrenia: Do we really need placebo-controlled studies? von Storosum, J.G, Elferink, A.J.A, van Zwieten, B.J

Volltext

ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders von Van den Brink, W., Montgomery, S.A., Van Ree, J.M., van Zwieten-Boot, B.J.

Volltext

Short-term efficacy of tricyclic antidepressants revisited: A meta-analytic study von Storosum, J.G, Elferink, A.J.A, Zwieten, B.J, van den Brink, W, Gersons, B.P.R, Broekmans, A.W

Volltext

Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention von Buitelaar, J.K., Montgomery, S.A., van Zwieten-Boot, B.J.

Volltext

Medical prescription of heroin to treatment resistant heroin addicts: two randomized controlled trials von van den Brink, W, Hendriks, V.M, Blanken, P, Koeter, M.W.J, Zwieten, B.J, van Ree, J.M

Volltext

Conduct disorder: guidelines for investigating efficacy of pharmacological intervention von Buitelaar, J.K., Montgomery, S.A., van Zwieten-Boot, B.J.

Volltext

Suicide risk in placebo-controlled trials for major depression von Storosum, J.G, van Zwieten-Boot, B.J, van den Brink, W, Gersons, B.P.R, Broekmans, A.W

Volltext

Amisulpride: Is there a treatment for negative symptoms in schizophrenic patiens? von Storosum, J.G, Elferink, A.J.A, van Zwieten-Boot, B.J, van Strik, R, Hoogendijk, WJG, Broekmans, A.W

Volltext

Placebo-controlled trials in schizophrenia von Storosum, J.G., Elferink, A., van Zwieten-Boot, B.J.

Volltext

Regulatory measures of clinically relevant response von van Zwieten-Boot, B.J.

Volltext

The nature of the amino acid pool used for protein synthesis in rat brain slices von Gispen, W.H, Reith, M.E.A, Schotman, P, Zwieten, B.J. van

Volltext